Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, Morgan Stanley Analyst Says

Tempus AI (NASDAQ:TEM) had its price objective boosted by Morgan Stanley from $68.00 to $80.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Morgan Stanley’s target price would indicate a potential upside of 9.07% from the company’s previous close.

Several other equities analysts also recently issued reports on the company. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Needham & Company LLC upped their target price on Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Guggenheim raised their target price on Tempus AI from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 26th. Piper Sandler decreased their price objective on shares of Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a research report on Tuesday. Finally, Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a research report on Tuesday, October 21st. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Tempus AI presently has a consensus rating of “Hold” and an average price target of $80.00.

Tempus AI Trading Up 2.2%

TEM traded up $1.57 on Tuesday, reaching $73.35. 2,290,004 shares of the company traded hands, compared to its average volume of 11,407,801. The company has a market cap of $12.74 billion, a P/E ratio of -61.71 and a beta of 4.86. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. Tempus AI has a one year low of $31.36 and a one year high of $104.32. The firm has a fifty day simple moving average of $85.83 and a two-hundred day simple moving average of $71.30.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Tuesday, November 4th. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. The business had revenue of $334.21 million for the quarter, compared to analyst estimates of $328.89 million. Tempus AI had a negative net margin of 18.45% and a negative return on equity of 73.21%. The company’s quarterly revenue was up 84.7% compared to the same quarter last year. During the same period last year, the company posted ($0.46) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, equities research analysts expect that Tempus AI will post -6.15 earnings per share for the current year.

Insider Buying and Selling

In related news, CFO James William Rogers sold 7,528 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the transaction, the chief financial officer directly owned 138,473 shares in the company, valued at approximately $10,337,009.45. This represents a 5.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director David R. Epstein sold 370 shares of the firm’s stock in a transaction dated Monday, November 3rd. The stock was sold at an average price of $90.00, for a total value of $33,300.00. Following the sale, the director directly owned 26,671 shares of the company’s stock, valued at $2,400,390. The trade was a 1.37% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 1,105,282 shares of company stock worth $87,726,381 over the last quarter. Corporate insiders own 26.27% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in TEM. Bank of New York Mellon Corp raised its holdings in shares of Tempus AI by 27.5% in the 1st quarter. Bank of New York Mellon Corp now owns 60,965 shares of the company’s stock valued at $2,941,000 after purchasing an additional 13,142 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Tempus AI by 37.0% during the 1st quarter. Envestnet Asset Management Inc. now owns 60,447 shares of the company’s stock worth $2,916,000 after acquiring an additional 16,328 shares in the last quarter. Brown Advisory Inc. purchased a new position in shares of Tempus AI in the 1st quarter valued at about $209,000. CWM LLC lifted its position in Tempus AI by 82.6% during the 1st quarter. CWM LLC now owns 155,536 shares of the company’s stock worth $7,503,000 after acquiring an additional 70,352 shares during the period. Finally, Signaturefd LLC acquired a new stake in Tempus AI during the 1st quarter worth approximately $48,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.